Praxis Medical Insights

Immediate Fracture Management

The American College of Physicians recommends initiating immediate pharmacologic treatment with oral bisphosphonates, combined with calcium and vitamin D supplementation, and implementing a multidisciplinary fracture care system that ensures surgery within 48 hours for operative fractures and orthogeriatric comanagement 1, 2
All fragility fractures require management within a multidisciplinary clinical system that guarantees adequate preoperative assessment, appropriate pain relief, fluid management, and surgery within 48 hours of injury for operative fractures, as recommended by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis 3
Orthogeriatric comanagement should be provided to improve functional outcomes, reduce hospital length of stay, and decrease mortality, particularly in elderly patients with hip fractures, according to the American Geriatrics Society 3
Most symptomatic vertebral fractures can be managed with analgesics, activity modification, and bracing; only 10% require hospitalization, as stated by the International Osteoporosis Foundation 3

The American College of Internal Medicine recommends bisphosphonates as the preferred initial pharmacologic treatment because they have the most favorable balance of benefits, harms, cost, and extensive clinical experience, with proven reduction in vertebral, non-vertebral, and hip fractures 1, 2
The National Osteoporosis Foundation suggests prescribing oral alendronate 70 mg weekly or 10 mg daily, OR risedronate 35 mg weekly, 150 mg monthly, or 5 mg daily, with generic formulations preferred to reduce costs 1, 2
Bisphosphonates reduce vertebral fractures by approximately 50% over 3 years in high-risk patients, according to the Cochrane Review 4

The American College of Internal Medicine recommends initiating anabolic agents, such as teriparatide or abaloparatide, as first-line therapy for very high-risk patients, defined as those with recent vertebral fracture, multiple fractures, or T-score ≤-3.5, followed by mandatory transition to an antiresorptive agent 1, 2
Patients initially treated with anabolic agents must receive an antiresorptive agent after discontinuation to preserve gains and prevent serious risk of rebound and multiple vertebral fractures, as stated by the Endocrine Society 1

The International Osteoporosis Foundation recommends repeating DXA scan in 1-2 years to assess treatment response, with significant BMD change defined as ≥1.1% based on facility protocol, and continuing DXA monitoring every 1-2 years during treatment 2
The American College of Internal Medicine suggests considering stopping bisphosphonate treatment after 5 years unless the patient has strong indication for continuation, as prolonged therapy beyond 5 years probably reduces vertebral fractures but not other fractures, while increasing risk for long-term harms 1

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis recommends systematically evaluating each patient aged 50 years and over with a recent fracture for risk of subsequent fractures using clinical risk factors, DXA of spine and hip, spine imaging for vertebral fractures, falls risk assessment, and identification of secondary osteoporosis 3
Older postmenopausal women at increased risk for falls and adverse events due to polypharmacy or drug interactions need individualized treatment selection based on comorbidities and concomitant medications, as stated by the American Geriatrics Society 1

The National Osteoporosis Foundation recommends educating patients about disease burden, fracture risk factors, follow-up requirements, and duration of therapy to improve adherence, and emphasizing that adequate calcium and vitamin D intake must be part of fracture prevention in all postmenopausal women with low bone mass or osteoporosis 1, 3
The American College of Internal Medicine suggests encouraging adherence to recommended drug treatments and healthy lifestyle modifications, including exercise and fall prevention counseling 1